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The Center of Excellence in Livestock Diseases and Human Health provides much needed support for some 
important research in the CVM. Funds are used to help support research by productive investigators with a 
track record of extramural funding. New investigators with projects having the most potential for securing 
extramural support and who can also obtain some departmental cost-sharing are also very carefully considered 
for support. In selected cases the COE funds are invested in some "start-up funds to enhance and accelerate 
the research of new faculty with promising research programs. 
The COE funding has been very successful in assisting some of our new faculty in submitting grants and 
successfully competing for outside funding. This support has helped cement ties with The Thompson Cancer 
Survival Center and their funding of research projects with Dr. Donita Frazier and Dr. Kevin Hahn. 
The concept of the COE stimulates collaboration between a multitude of different researchers and encourages 
sharing of equipment, ideas and many resources. Successful projects by researchers such as Drs. Linda 
Munson, Erby Wilkinson, Philip Bochsler, Doug Dawson and David Dean were all strengthened by initial COE 
support. These successful grants from outside funding agencies have included NIH, USDA, U.S. Air Force, 
EPA, as well as private corporations such as the American Cyanamid Company and the Upjohn Company. 
Several patents by Drs. Jack Oliver and Leon Potgieter have also resulted from projects initially funded, in part, 
by the COE. 
In these times of declining outside funding and increasing competition, the COE funds have also been used to 
bridge any gap in funding that some of our established researchers may temporarily encounter. 
Through the Venture Grant Program, the COE also helps fund a limited number of promising pilot projects 
submitted by residents and graduate students. 
A significant part of the continued growth and success of the College of Veterinary Medicine research program 
can be attributed to COE support in its many forms. Despite the financial hardships in the last two budgetary 
years, the CVM has managed to proceed with most of its plans due to careful fiscal control and COE support. 
Continued support from the COE will help us expand our research and continue to provide answers to some of 
the myriad of disease problems. Focusing on a few selected areas of research has also stimulated collaboration 
and sharing of ideas, equipment and other resources. The spirit of cooperation existing within our College is 
greatly enhanced by the support offered through the COE and the democratic and open process through which 
support is given. 
The COE is a significant factor in the success of this College and, to my mind, is an excellent example of 
minimal expenditure for maximum return. Continued support will help to maintain and, hopefully, expand our 
strong research foundation. 
GOALS 
Goal 1: 	 To improve the quality of human life through better animal health. 
Goal 2: 	 To augment livestock disease research capabilities in the Institute of 
Agriculture. 
Goal 3: 	 To identify and characterize animal diseases that are analogous to human 
diseases. 
Goal 4: To study these animal models for better understanding of human disease. 
GoalS: To understand the pathogenesis an characterize the causative agents of 
common disease important to Tennessee. 
Goal 6: To improve the capabilities of the College of Veterinary Medicine, the 
College of Agriculture and the Agricultural Experiment Station to deal with 
these diseases. 
Goal 7: To improve facilities to enable the College of Veterinary Medicine to study 
more effective infectious and toxic diseases affecting animals. 
GoalS: To disseminate through the Extension Service the practical information 
required to reduce the incidence of livestock diseases. 
Goal 9: To develop new strategies for the prevention of disease. 
Goal 10: To enhance the College's ability to recruit superior faculty and graduate 
students and to attract more external funding for research. 
Goal 11: To improve facilities an expertise in order to provide improved research 
training. 
Goal 12: To develop innovative approaches to the treatment of human disease. 
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1 Programmatic Report 
I. PROGRAMMATIC REPORT 
LA PERSONNEL CHANGES 
LA1. Personnel Additions 
Dr. Charmi Mendis-Handagama and Dr. Teresa Rowles, who hold 
appointments in the Department of Animal Science are being added this year to 
the Center of Excellence Faculty. Dr. Mendis-Handagama received her D.V.M. 
from the University of Sri Lanka, Peradeniya and her Ph.D. from Monash 
University, Melbourne, Australia. Dr. Teresa Rowles received her D.V.M. from 
The University of Tennessee and her Ph.D. from Texas A&M University. 
1.A.2. COE Members Leaving 
Dr. Clinton Lothrop resigned from the University in February 1992 to 
accept a position in the Scott-Ritchey Research Center at Auburn University. He 
will maintain close ties with the college in collaboration with both the Growth 
Factor and Oncology groups. 
Dr. Jeanne Maddux resigned in May 1992 to move to Alaska. 
1.A.3. Graduate and DVM Student Opportunities 
With the transition to a four-year, semester system, the College has been 
able to initiate a program to provide veterinary students experience in animal 
model-based biomedical research. This 12-week summer program focuses on first 
and second year veterinary students who have maintained a high academic 
standing and who have shown an interest in research. This experience should 
accelerate completion of their Ph.D. programs. 
The Department of Comparative Medicine, UT/Memphis, in collaboration 
with the Comparative and Experimental Medicine Program is seeking to establish 
a postdoctoral graduate program in laboratory animal/comparative medicine. 
This program will be for the purpose of preparing graduate veterinarians to 
become productive members of the biomedical research community as specialists 
in laboratory animal medicine, and to attain board certification in the American 
College of Laboratory Animal Medicine. 
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1.B. RENOVATION OF FACILITIES AND EXPANSION OF SERVICES 
1.B.1 Animal Facilities Improvements 
With support from the Center of Excellence, Dr. Edward Schroeder, 
Laboratory Animal Veterinarian was able to apply for, and receive funding from 
the National Institutes of Health, for improving the use of space by incorporating 
isolation technology and labor saving equipment. The improvements have 
allowed a measure of flexibility and efficiency and has provided a higher level of 
animal care. With newly funded faculty coming into the college, as well as the 
onset of new faculty positions, these renovations have made it possible to have a 
variety of rodent species in special environments. In addition, the new equipment 
has improved cleaning methods and reduced the risk of cross contamination when 
cages are changed. 
1.B.2 Library Services Added 
The library has instituted several new services that impact on agriculture 
and veterinary medicine. With the addition of AGRICOLA, the largest and most 
comprehensive source of U. S. agricultural information, and CAB ABSTRACTS, 
an International research database of agricultural information and the source of 
information for veterinary mediCine, human nutrition, developing countries, 
leisure, recreation, and tourism, faculty have the major indexes for agriculture and 
veterinary medicine available for searches anytime. 
1.C. SPECIAL MATERIALS AND EQUIPMENT 
A protein microsequenator, a DNA synthesizer, an upgraded HPLC, and a 
Doppler ultrasound attachment were purchased for college-wide use. Individual 
departments were also allocated funds for specific equipment items (e.g., Queue 
incubator, electroelution unit; Gene amplification polymerase system and gel 
dryer; and Coulter counter) for individual and department-wide use. 
1.D MAJOR PROGRAMMATIC ACTIVITY 
1.D.1 	 Research '92 
Research '92 was the college's 5th annual presentation of current research. 
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Through the UT Office of Research and Technology Development, the college 
was awarded a Hertel Grant, to partially sponsor the program. The first day of 
activities entailed the Distinguished Lecture Series which was presented at the 
University Center on the Main Campus followed by a Reception and Poster 
presentation. On day two, the program returned to the Veterinary Teaching 
Hospital with 11 presentations by senior and junior faculty, graduate students, and 
residents. The exposure provided campus-wide attention to many of the excellent 
research activities taking place at the College of Veterinary Medicine, and 
brought enhanced interaction among various members of the campus and off­
campus biomedical sciences community and College of Veterinary Medicine 
faculty. 
Additionally, Research '92 provided an easy way for potential graduate 
students to learn of research activities within the College of Veterinary Medicine 
that may be of interest to them, and provided positive publicity for research at the 
College and University. 
l.D.2 Minority Recruitment 
Because of a genuine interest by faculty, students, and staff, more minority 
applicants are giving consideration to the various programs within the college. 
Specific interest areas are the DVM program, graduate student program, and 
residency programs in both Rural and Urban Practices. 
With the addition of teachers to the Minority High School Apprentice 
Program sponsored by the National Institutes of Health, we are already 
experiencing extra incentive and visibility and more interest in veterinary medicine 
and the biomedical sciences from students. 
The college has added 10 students from the Upward Bound Program to its 
summer science experience. This six-week program includes students from 
different states. 
l.D.3 Collaborative Research Projects 
With recent notification from the NIH National Eye Institute of funding 
for his competitive renewal entitled Immunopathological Mechanisms in Herpetic 
Stromal Keratitis, Dr. Barry Rouse in collaboration with Dr. Deborah Distephano 
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in the Department of Ophthalmology at The University of Tennessee, 
Chattanooga, will continue to further define the role of CD4 + T lymphocytes in 
Herpes simplex virus (HSK) as well as the part played by CD8 + T cells at 
modulating the HSK reaction. 
A collaborative project with Oak Ridge on which Dr. Erby Wilkinson 
serves as principal investigator is entitled The Immunobiology of the Scurfy Mouse 
and relates to cellular immunology and the role of the microenvironment of the 
thymus in the production, selection, and export of functional T cells. The Scurfy 
(sf) mutant mouse forms an interesting model for such studies. Scurfy mice 
develop a severe x-linked lymphoproliferative disease that primarily affects skin 
and lymphoid organs and is an early cause of death. Several pieces of evidence 
implicate the thymus in development of the scurfy phenotype, and investigations 
are underway to better understand the pathogenesis of this disease. Such data is 
likely to enhance the investigator's understanding of the role of the thymus in T­
cell differentiation. Dr. Barry Rouse is also a collaborator on the Scurfy mouse 
project. 
In another collaborative effort, Dr. Hildegard Schuller is now embarking 
on a major venture as evidenced by her recent submission of an NCI Program 
Project. This $7 million project encompasses two medical schools within the 
United States and one outside the country, and three faculty members in the 
college. The project will link basic and clinical approaches to targeting mitogenic 
signal transduction pathways for the development of novel means of lung cancer 
therapy. While most lung cancer types generally do not respond to conventional 
radio- and chemotherapy, small cell cancer, a highly malignant neuroendocrine 
form of the disease, often demonstrates an initial response. However, in most 
cases, multi-drug-resistance develops, thus rendering the mortality rate of lung 
cancer in general at 90%. Preliminary data strongly suggests that B859-35 and 
similar agents may inhibit the continuous proliferation of lung cancers whose 
proliferative activity depends on Ca2+/calmodulin/protein kinase C mediated 
signal transduction loops. Dr. Sch filler is a leading researcher in the field of basic 
lung cancer research at both a national and international level. Funding of this 
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project would help establish an oncology center within the College of Veterinary 
Medicine. 
Dr. Terry Schultz in collaboration with Dr. Mark Kot is examining ways of 
monitoring and modeling biological chaos using an environmentally controlled 
microbial system. A major effort is underway to examine the usefulness of 
double-Monad systems. This unique blend of experimental and modeling science 
in the past two years has been funded by the National Science Foundation and is 
currently being funded by the Department of Energy. 
FETAX is fast becoming recognized as the premier non-mammalian system 
for the study of toxicant effects on development. A standard guide for conducting 
the assay has been published by the American Society for Testing and Materials. 
FETAX is now required for evaluation of sediment toxicity in the state of 
Washington. Dr. Doug Dawson is involved in an interlaboratory validation study 
with researchers from Oklahoma State University, the U. S. Army, the University 
of Maryland, Stover Biometric, and other laboratories around the country. Upon 
completion of the project, the EPA is expected to require FETAX testing in the 
process of pesticide registration. 
l.D.4 Dissemination of Information 
Research at the college has been highlighted by the media nationally, 
statewide, and locally during the past year. CNN featured ongoing research 
related to production of the red panda, a threatened species. The features aired 
several times in June as part of the CNN evening news, then was aired as a 
segment in a half hour CNN series called "Science and Technology Week." A 
public television series called "The Gentle Doctor" spent two days at the college 
in taping a segment for the nationally broadcast series about veterinary medicine. 
The feature will air during the 1992-93 seasons. Veterinary research is routinely 
featured on Tennessee television news programs in Knoxville. In addition, a 
television station from Nashville produced a lengthy news feature on the college 
in 1992. Newspaper articles have covered a wide range of research news and 
profiles of college faculty. Topics have included cancer research, toxic agents 
affecting cattle, auto-immune disease, as well as features on a new department 
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head and on other members of the faculty. Members of the Infectious Diseases 
and Population Medicine Group continue to work through Extension Service 
veterinarians to transfer the latest information on livestock diseases to the public. 
The college is also featured regularly in UT publications, including UT Agriculture, 
a magazine distributed to the Tennessee agricultural community and alumni; UT 
Alumnus, sent to graduates and contributors of the university statewide; 
Torchbearer, a UTK alumni publication; and Context, the UTK faculty and staff 
newspaper. Additionally, the college disseminates information through its own 
newsletter, Veterinary News, sent to Tennessee veterinarians and college alumni, 
and through other informational brochures for veterinarians and the general 
public. Information is also dispersed through the UT Extension Service 
veterinarians. They have regular newspaper columns statewide and respond to a 
variety of questions from Tennessee farmers and pet owners. They contribute to 
an extension service newsletter called Veterinary Topics, which is distributed to 
Tennessee veterinarians. 
I.D.S Major Research Areas 
GROWTH FACTORS GROUP 
The major emphasis of Dr. Robert Shull's research program is to treat 
dogs with mucopolysaccharidosis I by insertion of the gene for the deficient 
enzyme a-L-iduronidase into their bone marrow cells. Canine iduronidase has 
been purified, sequenced, and the gene cloned. Retroviral vector technology is 
being used to insert the gene into cultured bone marrow stem cells which will 
then be returned to the dog. A major effort is being made to use various novel 
stem cell factors as c-kit ligand to stimulate stem cells to divide and incorporate 
the new gene. If this is successful, the canine experiments may pave the way for 
replacement gene therapy in children with similar diseases. They are also 
planning on investigating the effects of direct injections of recombinant enzyme 
into MPS I-affected dogs. Notification from NIH that their competitive renewal 
has been funded assures Dr. Shull's collaboration with scientists at UCLA and 
USC in Los Angeles for at least S more years. 
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One of Dr. Linda Munson's long range research goals is to understand the 
regulation of placental growth by endogenous growth factors. Her proposed 
research investigates the role of transforming growth factors (TGFs) in controlling 
proliferation and adhesion of trophoblastic and endometrial epithelial cells at the 
maternal/fetal interface in developing bovine placentas. She is exploring the 
possibility that a novel mechanism of communication occurs between fetal and 
maternal tissues in the developing placenta called "juxtacrine." 
The research performed in Dr. James Godkin's laboratory focuses on the 
fetal-maternal interactions that are responsible for the maintenance of pregnancy 
and the growth and development of the embryo. His work has concentrated on 
proteins produced by fetal placental membranes. Most recent studies have 
centered on vitamin A (retinoid)-associated proteins. It has been recognized for 
over 50 years that vitamin A (retinol) is essential for reproduction. Recently a 
natural vitamin A metabolite, retinoic acid (RA), has been identified as a 
morphogen that dictates pattern formation in developing embryos. The action of 
retinoids (vitamin A and its analogs) is believed to be mediated by a 
plasmalextracellular transport protein, retinol-binding protein (RBP), two 
intracellular binding proteins (CRBP, CRABP), and RA nuclear receptors 
(RAR's). They have recently discovered that all of the placental extraembryonic 
membranes and the uterus synthesize RBP. They are currently investigating the 
molecular expression of the retinoid associated proteins in developing embryos 
and maternal uterine tissues. 
Cloning the gene for thrombopoietin (TPO) remains one of the major 
goals of Dr. Ted McDonald. The role of TPO in regulation of thrombocytopoiesis 
has recently become clearer and the use of TPO in treating patients with platelet 
production disorders appears appropriate. During the last year, they have made 
progress in cloning the gene for thrombopoietin by adding to the amino acid 
sequence of the molecule and gained helpful insight into TPO's stability in various 
aqueous solutions. 
During the last year, they have used TPO as a radioprotective agent for 
treating mice after whole-body irradiation. The results show that irradiated mice 
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treated with TPO had higher platelet counts and increased %35S incorporation 
into platelets than did irradiated controls. These results suggest that TPO therapy 
will modulate the severe thrombocytopenia that occurs in irradiation-induced 
bone marrow suppression and indicates great clinical promise for this regulatory 
factor. 
ONCOLOGY GROUP 
Dr. Mark Miller, in collaboration with Dr. Hildegard Schiiller, has been 
studying the effects of cigarette smoking as a causative agent in lung cancer. They 
have been using an animal model system, developed at The University of 
Tennessee by Dr. Schiiller, to explore the molecular mechanism of cancer 
causation with the ultimate goal of trying to develop novel anti-cancer drugs that 
would be targeted to the specific genetic lesions responsible for tumor growth. 
The animal model they have employed involves the treatment of hamsters 
with nitrosamines, a class of carcinogenic compounds that are prevalent in 
cigarette smoke, under conditions of increased oxygen levels. This treatment 
regimen results in the formation of a specific type of lung cancer that exhibits 
neuroendocrine features. This animal model is the only known model that 
produces neuroendocrine lung tumors. Their results have shown that the hamster 
tumors show the same types of genetic lesions as found in human small cell lung 
cancers. They will also continue to explore ways to inhibit tumor growth based on 
their findings of enhanced gene expression in these tumors. They have also been 
studying the potential effects of cigarette smoking combined with ethanol 
consumption during pregnancy. These studies should provide further information 
on environmental risk factors for lung cancer formation, and emphasize the 
potential risks to the fetus of exposure to ethanol and potential carcinogenic 
agents found in cigarette smoke. 
Recent efforts of the Predictive Toxicity Program has centered studies of 
aryl alcohols and aldehydes. Specifically, Dr. Terry Schultz's laboratory has 
identified that addition of one or more aromatic rings to the carbon atom 
attached to a hydroxyl group is a sufficient alteration in molecular structure to 
cause a change in mechanism of toxic action. They have completed the 
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development of the gas-tight lethality assay. Moreover, they have tested large 
numbers of electrophilic aldehydes. Comparing relative toxicities for aldehydes in 
the gas-tight assay with those in the more conventional growth assay revealed that 
the presence of pep tides and nucleic acids in the medium used in the growth assay 
modulates the toxic response of the direct-acting electrophiles by acting as 
nucleophiles. These findings have been validated by analyses of data from other 
test systems and go a long way in explaining the disparities in the literature on 
aldehyde toxicity. 
Present work by Dr. Doug Dawson involves basic research into the way 
chemical mixtures interact to induce malformations (Le., birth defects) in 
developing vertebrate animals. This research has led to the development of a 
technique which can be applied to the fields of aquatic and developmental 
toxicology. Work is also underway examining a series of carboxylic acids, in order 
to determine the compounds that have the greatest potential to cause birth 
defects. This work leads to the development of mathematical equations which can 
then be used to predict the potential hazard for any structurally similar chemical, 
without having to test the chemical. Therefore, the methodology has the potential 
to reduce the numbers of animals needed in toxicological testing. 
INFECTIOUS DISEASES AND POPULATION MEDICINE 
Dr. Steve Oliver's studies from last year have identified suitable 
microbiological procedures for identification of Streptococcus uberis and other 
Streptococcus species. He recently reported on a new technique to differentiate 
Strep. uberis from the closely related Strep. parauberis by polymerase chain 
reaction and restriction fragment length polymorphism analysis of 16S ribosomal 
DNA This technique will be of considerable importance in subsequent studies on 
the epidemiology and pathogenesis of Strep. u beris mastitis. An identification 
scheme for Streptococcus and Enterococcus species was also developed based on 
the same analysis. Procedures are now available for genetic identification of 
Streptococcus and Enterococcus species of bovine origin. Dr. Oliver has recently 
received funds from The Upjohn Company to work on a study entitled 
Immunization of Dairy Cows Against Strepococcus uberis. 
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A major challenge in both human and veterinary medicine today is the 
development of targeted methods to specifically interrupt virus infections that are 
persistent within the host and lead to chronic diseases. Coronaviruses are 
ubiquitous in nature causing a wide variety of disease in animals. Dr. David 
Brian's laboratory is the first in the world to report the existence of an intraleader 
open reading frame and its development (selection) during persistent infection. 
His objective is to examine in detail how variant leader structures regulate 
translation rates. In the last two years, two other virus families, the toroviruses (a 
cause of gastroenteritis in calves, horses, and possibly humans) and arteriviruses (a 
cause of equine arteritis) have been placed along with coronaviruses into a 
coronavirus superfamily. These all share a common strategy of RNA 
transcription, and possibly replication. Thus, what they describe as mechanisms of 
coronavirus persistent infection may be pertinent to these other families as well. 
Infection with bovine viral diarrhea virus (BVDV) results in tremendous 
losses to cattle farmers annually. The major envelope protein of BVDV is the 
only virally-encoded polypeptide consistently precipitated with BVDV antisera, 
and is the target for neutralizing antibodies. Dr. Leon Potgieter's laboratory has 
cloned and sequenced the genomic sequence encoding this glycoprotein from a 
noncytopathic strain of BVDV. Additionally, they have subcloned this viral 
sequence into a baculovirus expression system that provides for production of 
large amounts of properly processed viral protein. They hope to gain insight into 
the immune response induced by this important viral agent, as well as evaluate 
the potential usefulness of a recombinant vaccine consisting of BVDV structural 
proteins. Dr. Potgieter's goal is to use the viral protein produced in this system to 
define the immunogenicity of the major envelope protein and use it for 
immunization of cattle against this serious infection. 
Recent studies have determined potential toxicity of individual alkaloids 
that are present in fescue grass infected with the fungus Acremonium 
coenophialum. Dr. Jack Oliver's laboratory has been the first to show, in cattle, 
biological activity associated with three of the five major alkaloid types found in 
toxic fescue. Results of these studies indicate that the various alkaloid types that 
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are present in toxic fescue, have greater or lesser effects on specific tissue 
receptors that control organ function. Thus, it appears it will be difficult to 
develop a singular chemical agent to block all of the various effects of toxic fescue 
alkaloids. 
Other studies have led to the development of a model system in cattle that 
allows the effects of individual alkaloids to be studied over a period of time. 
Alkaloids are constantly administered to animals by a miniature pumping device 
that is implanted under the skin. This system mimics the natural situation where 
cattle consume the toxic alkaloids while grazing, but has the advantage of looking 
at toxicity caused by a single alkaloid, where the concentration and amount of 
alkaloid that the animal actually is exposed to is known. 
Because of the difficulty of controlling the toxic fescue condition in cattle 
with drugs, Dr. Oliver's research group has examined the possibility of developing 
an anti-fescue-toxicosis vaccine. They have just received verbal communication 
from Schering-Plough that they will fund their project to develop this method of 
fescue toxicity control in cattle. 
INFLAMMATION GROUP 
Dr. Barry Rouse's laboratory is attempting to verify their hypothesis that 
herpetic stromal keratitis, a common cause of ocular impairment, including 
blindness, represents an inflammatory response by the host, within the eye, to 
some components of the virus. They are seeking to establish the mechanisms of 
this reaction and ultimately find some immunological means of controlling it. 
Their recent results have provided further direct evidence that a single subset of T 
lymphocytes, the CD4 + subset, are primarily involved in the immunopathology. 
This was shown by transferring cells of known identity and reactivity into animals 
whose own immune response had been compromised. 
A second mission in Dr. Rouse's laboratory is involved with evaluating the 
optimal means of inducing CD8 + T lymphocytes with soluble proteins and 
nonreplicating viral antigens. They have used several approaches to this issue 
including the demanding task of generating primary CD8+ T cell mediated 
cytotoxicity completely in vitro. They have achieved success finding that two 
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conditions are particularly important. These are the delivery of antigen within pH 
sensitive liposomes and the use of a particular cell type, the dendritic cell, as a 
means of delivering antigen. 
Bacteria of the gram-negative type produce a toxin that is commonly 
referred to as endotoxin. Because of its molecular structure, endotoxin is also 
referred to as lipopolysaccharide, or simply LPS. In most cases, LPS does not act 
directly on body tissues to cause sickness, but acts through the animal's own 
immune system. 
There is evidence that humans and some animals are stimulated to 
synthesize a novel protein whenever they are exposed to the bacterial toxin LPS. 
This protein is found circulating in the blood, and binds to the LPS molecule. 
Because of this, it is called LPS-binding protein, or LBP. Once LBP and LPS are 
bound, they attach to a receptor on cell surfaces called CD14. When this occurs, 
the immune system becomes even more aware of the presence of the bacterial 
toxin LPS. Although cattle are commonly afflicted by disease causing bacteria 
that produce the LPS toxin, this important protein (LBP) and receptor (CD14) had 
not been studied in cattle. The purpose of Dr. Philip Bochsler's work is to study 
bovine LBP and CD14 in order to better understand how bacterial LPS affects 
cattle, which may ultimately contribute to improved treatment and control of 
gram-negative bacterial infections of cattle. 
Some of the work in Dr. David Slauson's laboratory is directly aimed at 
major disease problems in livestock, including increased susceptibility of new born 
calves to life-threatening bacterial infections and the mechanisms of signal 
transduction in bovine leukocytes. In recent years, they have been -able to 
document that leukocytes from new born calves exhibit marked functional 
differences in respiratory burst activation, an important bactericidal system, as 
well as in leukocyte membrane reactivity to complement stimulation. Dr. Slauson 
has also been studying the transmembrane and intracellular signalling pathways 
used by bacterial endotoxin in bovine lung macrophages. 
Dr. Michael Breider has studied the effect of live and dead Pasteurella 
haemolytica on bovine pulmonary endothelial cell (EC) monolayer cultures. He 
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found the proliferation of live bacteria leads to severe EC toxicity and dead 
bacteria can produce a similar EC toxicity, although a larger inoculating dose 
must be given. The addition of polyclonal anti-£. haemolytica bovine serum and 
neutrophils protect the EC from live £. haemolytica, but not dead £. haemolytica. 
However, the addition of polymyxin B effectively protects EC, presumably by 
neutralizing the bacterial endotoxin. These studies clearly demonstrate that 
endotoxin is an important bacterial virulence factor, and the host defense system 
of neutrophils and immune serum may protect against proliferation of P. 
haemolytica in the lung but cannot protect against the endotoxin associated EC 
damage. 
l.D.6 Projects that Benefitted from COE Support 
Dr. Erby Wilkinson has just received verbal notification that his grant 
submissions to NIH titled Molecular Genetics of Polycystic Kidney Disease in the 
Transgenic Tg737 Mouse and Immunobiology of the Scurfy Mouse have both been 
funded to begin September 1, 1992. Both of these awards are a direct reflection 
of COE start-up monies. Dr. Philip Bochsler's USDA grant titled Bovine 
Lipopolysaccharide Binding Protein and Mechanisms of Macrophage Activation is a 
result of starter monies from COE and Dr. David Dean's NIH Fellowship 
application entitled Signalling Pathways in LPS-stimulated Lung Macrophages which 
was funded was strengthened because of COE support. 
Additionally, several projects supported in part by COE have resulted in 
patents. Dr. Jack Oliver has received a patent, "Development of an Anti-Fescue 
Toxicosis Vaccine" issued by the U. S. Patent Office on 1/21/92, U. S. Patent 
Office #07/823, 146, UT Research Corporation File No. 91-16, and applied 
February, 1992, for a second patent "Biomedical Use of Loline Alkaloids," UT 
Research Corporation File No. 92-11. Dr. Hugo Eiler received a patent for 
"Method for Treatment of Bovine Retained Placenta," U. S. Patent No. 5,089,264, 
UT Research Corporation File No. PD 89-44 issued on February 18, 1992. 
New faculty who have just been awarded startup funds from COE to 
enhance extramural opportunities are: 
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• 	 Dr. Kevin Hahn, an assistant professor with joint appointments in 
Environmental Practice and Urban Practice, is involved in both 
basic and clinical oncology research. He is collaborating with Drs. 
Donita Frazier and Masoud Panjehpour to determine what 
treatment schemes induce the most sub-lethal DNA damage in 
surviving tumor cells. Their long-term objective of this research is 
to enhance tumor control. 
• 	 The development of in vitro models of central nervous system 
disorders or toxicities is of increasing importance both as screening 
and mechanistic tools. Free radicals, such as oxygen centered 
radicals, have been implicated in aging, which has special relevance 
in the central nervous system in investigations of senile dementias. 
Dr. Teresa Rowles is currently evaluating several neural cell lines of 
human origin. Such determinations will be useful in future grant 
applications for mechanistic and screening studies in the areas of 
ischemia/reperfusion and neurotoxicities. 
• 	 The Leydig cell produces the steroid testosterone in mammals. 
Testosterone is required for the development and function of the 
male reproductive tract. Dr. Charmi Mendis-Handagama will 
attempt to identify whether peroxisomes are involved in the 
transport and metabolism of cholesterol during steroidogenesis in 
Leydig cells, and study the mechanisms involved in biogenesis of 
peroxisomes in Leydig cells in response to LH stimulation. 
• 	 Dr. Linda Bravo, a 2nd-year Resident in the Department of Urban 
Practice is being funded by COE for a project entitled Serum 
Cytokine Concentrations in Normal Dogs and in Dogs with Lymphoma 
before and after Chemotherapy. Collaborating with Dr. Clinton 
Lothrop, Auburn University, Dr. Kevin Hahn, Departments of 
Environmental and Urban Practice, and The Thompson Cancer 
Survival Center, they will seek to determine the appropriate levels 
of recombinant cytokines to use in dogs post chemotherapeutic 
treatment. 
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(Final Year of 
Initial Commitment) 
1988-89 
Year 6 
(Year 01 as 
Accomplished Center} 
1989-90 
Year 7 
(Year 02 as 
Accomplished Center} 
1990-91 
YearS 
(Year 03 as 
Accomplished Center} 
1991-92 
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A. NUMBERS OF 
1. ARTICLES 
2. BOOKS OR BOOK CHAPTERS 
PUBLISHED 
3. PUBLISHED PROCEEDINGS 
TOTAL PUBLICATIONS: 2.82 
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2. National Meetings 
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19 
28 
(0.73) 
(1.08) 
28 
44 
(1.08) 
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36 
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RESEARCH PROJECTS FUNDED EXTERNALLY 

REPORT PERIOD 1991-92 

TOTAL AMOUNT ESTIMATED 
PROJECT DIRECTOR SOURCE AWARDED EXPENDITURES 
7-1-91 /6-30-92 
BOCHSLER, P. N. USDA Competitive 140,000 59,970 
J. M. Maddux & M. A. Breider 9/1/91-8/31/93 
co-investigators 
Bovine Lipopolysaccharide Binding 
Protein and Mechanisms of Macrophage 
Activation 
BREIDER, M. A. USDA Special 146,616 2,000 
Effects of Pasteurella 9/15/87-9/30/90 
haemo/vtica Pathogenic Factors (Extension to 9/30/91) 
on Bovine Pulmonary Endothelium 
BRIAN, D. A. NIH 565,311 94,080 
Corona virus Structure and 9/1/89-8/31/94 
Replication 
DAWSON, D. A. Society of Toxicology / 80,750 654 
Joint Action of Developmental U.S. Air Force 
Toxicants 7/1/89-7/6/91 
DAWSON, D. A. NIEHS/NIH 138,043 68,472 
SCHULTZ, T. W., Co-investigator 4/1/91-3/31/93 
Mixture Teratogenesis: Relation 
to Mechanisms and QSARs 
DEAN, D. NIH Training Grant 97,500 18,200 
(Research Fellowship) 11/30/91-11/30/94 
Signalling Pathways in LPS-
Stimulated Lung Macrophages 
GODKIN, J. & USDA Competitive 237,000 13,166 
Baumbach, G. A., Co-investigator 9/1/88-8/31/91 
Bovine Fetal-Maternal 
Interactions 
LOTHROP, C. D. NIH 862,438 151,488 
The Molecular Biology of 12/1/88-11/30/93 
Cyclic Hematopoiesis 
LOTHROP, C. D. Mathers Charitable 179,100 17,910 
Animal Models of Human Gene Foundation 
Therapy 1/1/87-12/31/91 
PROJECT DIRECTOR 
McDONALD, T. P. 
Contract--Development ofAssays 
for Thrombopoietin 
Performance ofAssays for 
Thrombopoietin 
MCDONALD, T. P. 
Thrombopoietin: Immuno­
assay & Characterization 
McDONALD, T. P. 
Purchase of: Cell Harvester 
System 
MUNSON, L. 
Effects of Progestagen Contraceptives 
on the Uterus & Mammary Glands of 
Exotic Felids 
OLIVER, J. W. 
Toxic Fescue Alkoloid Effects 
on Catecholamine Receptors in 
Bovine 
OLIVER, S. P. 
Mastitis Research 
OLIVER, S. P. 
Mastitis Research 
OLIVER, S. P. 
Factors Influencing Bovine 
Mononuclear Cell Function during 
the Nonlactating Period 
OLIVER, S. P. 
Mastitis Research 
OLIVER, S. P. 
Mastitis Research 
POTGIETER, L. 
Development of Technology for 
use in the Discovery and 
Production of a Commercial BVD 
Vaccine and Diagnostic 
POTGIETER, L. 
Genetic Organization of a 
Pneumopathic Strain of Bovine 
Viral Diarrhea Virus 
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SOURCE 
TOTAL AMOUNT 
AWARDED 
ESTIMATED 
EXPENDITURES 
7-1-91 /6-30-92 
Genentech 
3/1/88-2/28/93 
178,732 33,000 
3/1/88-7/31/93 112,700 20,808 
NIH 
12/1/88-11/30/93 
548,681 115,600 
NHLSI Small 
Instrumentation Program 
9/1/91-8/31/92 
8,253 8,253 
Nixon Griffis Fund 
(New York Zoological Soc.) 
3/1/91-2/28/92 
2,844 1,896 
USDA Special Grant 
9/1/89-8/31/91 
125,000 10,416 
Alcide Corporation 
12/90-12/94 
57,752 14,438 
Monsanto Agri Co. 
11/90-12/92 
25,576 12,788 
USDA-SEA 
9/90-9/92 
98,388 49,194 
H. S. Fuller Co. 
4/91-12/94 
31 ,778 8,664 
Upjohn Company 
10/91-12/94 
6,293 1,992 
Upjohn Company 
2/1/90-12/31/92 
75,000 24,996 
USDA Special 
Grant 
9/1/88-8/31/91 
149,200 8,386 
19 
PROJECT DIRECTOR 
POTGIETER, L. 
Cloning and Sequencing of BRSV 
G Glycoprotein and Detection 
of Strain Divergence 
ROUSE, B. T. 
Immunity Mechanisms in 
Herpesvirus Infections 
ROUSE, B. T. 
Keratitis Treatment with Drug-
containing Immunoliposomes 
ROUSE, B. T. 
Liposome Microencapsulation 
of Vaccine Antigens 
ROUSE, B. T. 
Herpes Zosterification 
SCHULLER, H. M. 
Transplacental 
Carcinogenicity of NNK 
SCHULLER, H. M. 
Mechanisms of Neuroendocrine 
Lung Carcinogenesis by 
Nitrosamines 
SCHULLER, H. M. 
Characterization of Induced 
Neuroendocrine Lung Cancer 
Characterization of Induced 
Neuroendocrine Lung Cancer 
SCHULLER, H. M. 
Contract--Testing of Anti-
carcinogenic Effects of 
Niguldipine 
SCHULLER, H. M. 
Air Pollutants and 
Neuroendocrine Lung Cancer 
SCHULTZ, T. W. & 
Kot, Mark, Co-investigator 
Chaos in Microbial Systems 
SHULL, R. 
Molecular Study of MPS I: 

Gene Therapy in a Canine Model 

Benchmarks 
SOURCE 
USDA Special 
Grant 
8/1/90-7/31/93 
NIH 
5/1/89-4/30/94 
National Eye 
Institute (NIH) 
9/30/87-9/29/92 
NIAID 
6/1/90-5/1/95 
SmithKline Biologicals 
12/15/89-12/31/94 
NIH 
9/1/89-11/30/92 
Shannon Award 
(NIH) 
9/1/91-8/31/93 
National Cancer 
Institute (NIH) 
7/1/88-6/30/91 
(Extension to 12/31/92) 
National Cancer 
Institute (NIH) 
2/7/92-1/31/95 
Byk Gulden 
Pharmaceuticals 
3/1/88-10/31/93 
EPA 
1/1/89-6/30/90 
(Extension to 8/31/91) 
NSF 
12/1/89-11/30/92 
NIH 
8/1/87-7/31/92 
TOTAL AMOUNT ESTIMATED 
AWARDED EXPENDITURES 
7-1-91/6-30-92 
149,974 50,679 
1,130,370 225,082 
708,050 153,519 
828,289 156,833 
124,746 24,948 
491,219 161,316 
100,000 41,670 
437,299 1,653 
409,781 75,380 
183,000 32,292 
98,104 6,132 
111,615 56,659 
1,105,183 107,510 
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PROJECT DIRECTOR 

SLAUSON, D. O. & 

BOCHSLER, P. N., Co-investigator 

Leukocyte Function and Host 
Defense in Developing Calves 
SLAUSON, D. O. 
Equine Endotoxemia: An in vitro 
Model of Endotoxin-mediated Disease 
WILKINSON, J. E. 

MUNSON, L., Co-investigator 

Role of TGF on Bovine Placental 
Growth and Development 
WILKINSON, J. E. 

LOTHROP, C. D., Co-investigator 

Development of Methods for 
Therapeutic Gene Transfer in Dogs 
WILKINSON, J. E. & 
GODKIN, J. , Co-investigator 
Transforming Growth Factors in 
Early Pregnancy in the Cow 
GRAND TOTAL 
Benchmarks 
SOURCE 
USDA Competitive 
9/15/90-9/30/92 
USDA Special 
9/1/90-8/31/91 
(Tranfer from Cornell) 
USDA Competitive 
8/1/89-7/31/91 
AVMA Foundation 
8/1/89-7/31/91 
(Extension to 12/31/92) 
USDA Special 
7/1/89-6/30/92 
TOTAL AMOUNT ESTIMATED 
AWARDED EXPENDITURES 
7-1-91/6-30-92 
120,000 60,000 
64,175 10,695 
160,000 6,667 
13,895 4,068 
149,653 49,884 
11,991,358 
• I 
j I I 
, \, 
'. 
PLANS 'FOR NEXT YEAR ', ' 

, ' 
Y, • 
\ !. 
< ' 
I ­
" , 
21 Plans for Next Year 
III. PLANS FOR NEXT YEAR 
With the acquisition of an Assistant Dean for Research and Graduate Programs, 
the college will be embarking on an era of renewed emphasis on scholarship. 
Responsibilities of the Assistant Dean will include coordinating all research and graduate 
study activities of the college. This position will enhance the college's visibility and 
strengthen its competitiveness in research and provide assistance in the day-to-day 
functioning of the Center. 
More directed focus will be given the collaborative graduate program with UT 
Memphis under the direction of David M. Renquist, DVM, MS, Chairman, Department 
of Comparative Medicine, UT Memphis. Specific bylaws will be constituted, followed by 
a formal enactment by the Graduate Council. An adjunct appointment with 
veterinarians at St. Jude Children's Research Hospital will be activated relating to course 
work, teaching, and training requirements. As proposed, approximately one half of the 
trainee's time will be devoted to residency training in laboratory animal science and 
medicine consisting primarily of participation in clinical rotations, weekly pathology 
conferences, and participating in teaching programs and seminars on topics related to 
laboratory animal science and medicine. Trainees will be involved in all aspects of the 
clinical care program, and will learn to conduct all procedures carried out in the 
diagnostic laboratory. Another important aspect of the training program will be the 
study of animal models for medical research. The remaining half of the trainee's time 
will be devoted to research training offered through one of the basic medical science 
divisions. Students will attend research seminars sponsored by various university 
research departments. 
Previously Biomedical Research Support Grant (BRSG) funds were received 
independently by the College of Veterinary Medicine and the Office of Research. The 
College of Veterinary Medicine and the Biomedical Science Departments in the College 
of Liberal Arts have agreed to cooperate in submitting a single proposal for BRSG 
funds. With this change in scope of "venture" applications, young and new faculty in the 
College of Veterinary Medicine will make application for BRSG funds through The 
University of Tennessee-Knoxville. Targeted areas most likely to receive funding are: 
(1) pilot research projects that show significant promise of leading to grant support from 
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NIH or some other funding agency; (2) new investigators will be given highest priority, 
but will be strongest when they show significant promise of achieving grant support from 
NIH or some other agency; and (3) unexpected needs for projects currently supported by 
NIH. These are proposals whereby funded investigators are experiencing unanticipated 
needs requiring urgent attention. The University of Tennessee will request a 1:1 match 
for BRSG funds. 
The External Advisory Committee will arrive in late October or early November 
for a site visit. Suggestions from the November 8, 1990, site visit have been 
implemented. It was suggested by the committee to support a "limited number" of 
programs. While the college originally focused on three program groups: Growth 
Factors, Inflammation, and Oncology groups, the External Advisory Committee 
recommended the formation of a fourth group, to be "broadly labelled an Environmental 
Studies and Livestock Diseases Group." The Infectious Diseases and Population 
Medicine group was established. An Internal Advisory Committee, under the direction 
of the Assistant Director of COE, was also instituted and is now in its second year of 
"advising the Director on the Center's program coordination and planning (goals)." The 
External Advisory Committee has been instrumental in the implementation of major 
goals and objectives of the college. The external review process will continue. However, 
the review team will undergo a reorganization as Dr. Henry Baker and Dr. Peter 
Doherty will rotate off. 
One of our major goals for next year is to strengthen research ties with ORNL. 
Dr. David Slauson will take the lead in these endeavors. Dr. Erby Wilkinson's two new 
grants from NIH will directly enhance our link with the Biology Division, ORNL. Drs. 
Virginia Godfrey and Laine Russell, of the Biology Division of ORNL, will be examining 
the role of the thymus and thymic cell components in scurfy induction in mice. 
In a second project, Dr. Wilkinson, along with Dr. Richard Woychik of the 
Biology Division of ORNL will be seeking to characterize the phenotype of the Tg737 
mouse including the clinical, pathologic, and clinicopathologic changes associated with 
PKD. 
A second major goal for next year is to broaden our oncology program. To that 
end, in an effort to strengthen ties with The Thompson Cancer Survival Center and in 
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collaboration with Dr. Donita Frazier, Dr. Michael Breider will make a transition from 
the Inflammation Group to the Oncology Group. Currently they are investigating the 
expression of angiogenic cytokines in several human tumor cell lines and have 
successfully demonstrated basic fibroblast growth factor in a squamous cell carcinoma 
line using Western blot techniques. They are also investigating photodynamic drug 
uptake by endothelial cells and methods to enhance drug uptake by the cells. Dr. Kevin 
Hahn has been brought into the group to provide the link between the clinical sciences 
and basic sciences. 
In addition, we plan to strengthen our Growth Factors Group with the addition to 
the Center of Dr. Charmi Mendis-Handagama. Similarly, the Oncology and Toxicology 
Group will be broadened with the addition of Dr. Teresa Rowles and her expertise in 
neurotoxicity. 
If Dr. Hildegard Schuller's Program Project Grant entitled "Signal Transduction as 
a Target of Lung Cancer Therapy" is awarded, it will enhance our status in expanding the 
Center's emphasis in Oncology and interinstitutional cooperative research. Project 
leaders from outside the UT system are: 
• 	 Dr. Kenneth L. Becker, project leader of the project "Modulation of 
Neuroendocrine Markers in Lung Tumors" will be directing the research 
effort from The George Washington University, Washington, D.C. (work 
will take place off-campus at the VA Medical Center). 
• 	 Dr. Andre Castonguay, project leader of the project "Effects of B859-35 on 
Carcinogen Activation" will be directing the research effort for Laval 
University, Quebec, Canada. 
• 	 Dr. Paul Bunn, project leader of the project "Clinical Investigations" will be 
directing the research effort for the University of Colorado, -Denver, 
Colorado. 
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Projects carried out within the college will be: 
• 	 Regulation of Lung Cancer Mitrogenesis by Receptors, Project Leader Dr. 
Hildegard Schuller 
• 	 Second Messenger Pathways in Lung Cancer Cells, Project Leader Dr. 
David Slauson 
• 	 Molecular Biology of Lung Tumors, Project Leader Dr. Mark Miller 
• 	 Electron Microscopy of Lung Tumor Cells, Project Leader Dr. Don 
McGavin 
The COE continues to be a strong influence and major support for many research 
programs in the CVM. The democratic manner in which funds are allocated for support 
of proposals underscores the spirit of cooperation and emphasizes the principle of shared 
resources. Funds for the COE are an example of a good investment in the future of 
Tennessee--minimal funds with maximum benefits. 
Continued support for our expanding research endeavors is essential. 
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SCHEDULE 1 
CENTERS OF EXCELLENCE 
ACTUAL, PROPOSED, AND REQUESTED BUDGET 
Institution College of Veterinary Medicine 
Center Livestock Diseases & Human Health 
1991-92 Actual Budget 1992-93 Proposed Budget 1993-94 Requested Budget 
Matching Appropriations Total Matching Appropriations Total Matching Appropriations Total 
levenue 
lew State Appropriation 517,900 517,900 506,500 506,500 532,000 532,000 
:arryover State Appropriation 2,422 2,422 
lew Matching Funds 258,950 258,950 253,250 253,250 266,000 266,000 
:arryover from Previous Matchin 821 821 
Total 259,771 520,322 780,093 253,250 506,500 759,750 266,000 532,000 798,000 
Ixpendltures 
:alaries 51,085 102,323 153,408 36,877 73,865 1l0,742 33,400 66,600 100,000 
'. 
I. 
e 
Faculty 
Other Professional 
ClericallSupporting 
~ssistantships
tudents 
54,891 
25,307 
7,99j3,05 
109,947 
50,691 
1~,~22
, 15 
164,838 
75'69824 21 
'1,100 
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,01 
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12,~2R15, 8 
165,920 
68,000 
1~,2582 ,00 
Total Salaries 142,335 285,098 427,433 124,035 248,425 372,460 125,975 251,195 377,170 
;ringe Benefits 27,541 55,163 82,704 32,245 64,595 96,840 30,660 61,140 91,800 
Total Personnel 169,876 340,261 510,l37 156,280 3l3,020 469,300 156,635 312,335 468,970 
'ravel 
:oftware 
242 
284 
488 
570 
730 
854 
1,665 3,335 5,000 300 700 1,000 
looks and 10urnals 
>ther Supplies 41,983 84,090 126,073 41,355 82,095 123,450 44,432 88,598 l33,030 
~uipment 
.1aintenance 
41,546 
5,840 
83,213 
11,700 
124,759 
17,540 
49,950 
4,000 
100,050 
8,000 
150,000 
12,000 
58,450 
6,183 
116,550 
l3,817 
175,000 
20,000 
;cholarships 
:onsul tams 
tenovation 
>ther (Specify) 
-
Total Non·Personnel 
GRAND TOTAL 259,771 520,322 780,093 253,250 506,500 759,750 266,000 532,OCO 798,000 
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CURRICULUM VITAE 
S. M. LILITHA CHAMINDRANI MENDIS-HANDAGAMA 
Education: Degree Year Field of Study 
Monash University Melbourne, Australia. PhD. 1985 Reproductive Biology. 
University of Sri Lanka, Peradeniya. DVM. 1977 Vet. Med. & Surgery. 
The Johns Hopkins University, Baltimore. -postdoctoral training- Reproductive Biology. 
Career History: Assistant Professor, Department of Animal Science, The University of Tennessee, 
1991-present; Research Associate, Department of Population Dynamics, The Johns Hopkins 
University, 1990-1991; Postdoctoral Fellow, The Johns Hopkins University, 1985-1989; 
Research Assistant, Monash University, Australia, 1984-1985; Doctoral Student, Monash 
University, Australia, 1980-1984; Lecturer, Department of Veterinary Pre-Clinical Studies, 
University of Srilanka, 1977-1980. 
Honors and Awards: Recipient of 1992 Idea Grant, Awarded by the Institute of Agriculture, UT; 
recipient of Participation Award for 8IeSS awarded by the March of Dimes Organization, 1991; 
Institutional Scholarship, awarded by The Johns Hopkins University, 1985-1989; Postdoctoral 
Fellowship, awarded by the Mellon Foundation, 1986-1987; recipient of Hans Elias Award for 
Distinguished Young Stereologists, awarded by the International Society for Stereology, 1987; 
Trainee Travel Award, awarded by the Society for the Study of Reproduction, 1987; Postdoctoral 
Fellowship, awarded by the Hewlett Foundation, 1985-1988; Monash Graduate Scholarship, 
awarded by the Monash University, 1983-1984; Postgraduate Research Scholarship, awarded by 
the World Health Organization, Switzerland, 1980~1983; Commonwealth Bureau of Animal 
Health Award, awarded by the Commonwealth Bureau of Animal Health, England, 1975. 
Invited Speaker in International Conferences: M.C. Chang Memorial Conference, Barcelona, 
Spain, 1992. 
TournaI Reviews: Journal of Andrology, Biology of Reproduction, Molecular & Cellular 
Endocrinology. 
Publications (Last 5 years): 
1. 	 Mendis, S.M.L.C. (1985). Studies on Leydig cells: their development, heterogeneity and 
response to tubule damage. Ph.D. Thesis. Monash University, Melbourne, Australia. 
2. 	 Mendis-Handagama, S.M.L.C., Risbridger, G.P., de Kretser, D.M. (1987). Morphometric 
analysis of the components of the neonatal and adult rat testis interstitium. Int. J. Andro1. 
10:525-534. 
3. 	 Hardy, M.P., Mendis-Handagama, S.M.L.C., Zirkin, B.R., Ewing, L.L. (1987). 
Photoperiodic variation of Leydig cell numbers in the testis of the golden hamster: a 
possible mechanism for their renewal during recrudescence. J. Exp. Zoo1. 244:269-276. 
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4. 	 Mendis-Handagama, S.M.L.C., Zirkin, B.R., Ewing, L.L. (1988). Comparison of 
components of the testis interstitium with testosterone secretion in hamster, rat and 
guinea pig testes perfused in vitro. Am.J.Anat. 181:12-22. 
5. 	 Walters, J.R., Juniewicz, P.E., Oesterling, J., Mendis-Handagama, S.M.L.C., Zirkin, B.R., 
Ewing, L.L. (1988). The effect of inhibition of aromatase enzyme activity on Leydig cell 
structure and function in beagles. Endocrinology 123:2223-2229 
6. 	 Keeney, D.S., Mendis-Handagama, S.M.L.C., Zirkin, B.R., Ewing, L.L. (1988). Effect of 
long-term deprivation of luteinizing hormone on Leydig cell volume, Leydig cell number 
and steroidogenic capacity of the rat testis. Endocrinology 123:2906-2915 
7. 	 Mendis-Handagama, S.M.L.C., Hardy, M.P., Keeney, 0.5., Ewing, L.L. (1989). 
Application of the disector method to enumerate cells in the testis. In: Regulation of 
testicular function: signaling molecules and cell-cell communication, L.L. Ewing and B. 
Robaire (ed), The New York Academy of Sciences, NY (Publisher), 564:86-98. 
8. 	 Mendis-Handagama, S.M.L.C., Ewing, L.L. (1990). Sources of error in the estimation of 
Leydig cell numbers in control and atrophied mammalian testes. J. Microscop. (Oxford) 
159:73-82. 
9. 	 Mendis-Handagama, S.M.L.C., Zirkin, B.R., Scallen, T. J., Ewing L.L. (1990). Studies on 
peroxisomes of the adult rat Leydig cell. J. Andrology 11:270-278. 
10. 	 Mendis-Handagama, S.M.L.C., Kerr, J.B., de Kretser, D.M. (1990). Experimental 
cryptorchidism in the adult mouse I. Qualitative and quantitative light microscopic 
morphology. J.Andrology 11:539-547. 
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Peroxisomes are responSible for the transport of cholesterol from lipid droplets into 
mitochondria by sterol carrier protein-2 during luteal cell steroidogenesis. Proc. Am. 
Soc. Cell BioI. Abstract 1356. 
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